Cargando…
Physical Activity Protects the Pathological Alterations of Alzheimer’s Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways
Alzheimer’s disease (AD) is a neurodegenerative disorder with typical amyloid beta (Aβ) aggregations. Elimination of the Aβ precursors via the kidneys makes the organ a potential factor in the systemic degeneration leading to AD. Pituitary adenylate cyclase-activating polypeptide (PACAP) exerts neur...
Autores principales: | Perényi, Helga, Szegeczki, Vince, Horváth, Gabriella, Hinnah, Barbara, Tamás, Andrea, Radák, Zsolt, Ábrahám, Dóra, Zákány, Róza, Reglodi, Dora, Juhász, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457084/ https://www.ncbi.nlm.nih.gov/pubmed/32922265 http://dx.doi.org/10.3389/fncel.2020.00243 |
Ejemplares similares
-
Physical Training Inhibits the Fibrosis Formation in Alzheimer’s Disease Kidney Influencing the TGFβ Signaling Pathways
por: Szegeczki, Vince, et al.
Publicado: (2021) -
Alzheimer’s Disease Mouse as a Model of Testis Degeneration
por: Szegeczki, Vince, et al.
Publicado: (2020) -
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
por: Szegeczki, Vince, et al.
Publicado: (2019) -
Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Reduces Oxidative and Mechanical Stress-Evoked Matrix Degradation in Chondrifying Cell Cultures
por: Szentléleky, Eszter, et al.
Publicado: (2019) -
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
por: Józsa, Gergő, et al.
Publicado: (2019)